+359.6%
MRNA vs PLTD
-76.0%
+435.6%
-53.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | PLTD | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | 0.0% | -4.8% | -4.8% |
| 7D | -20.9% | +9.7% | -30.5% | -18.6% |
| 30D | -13.3% | +21.7% | -34.9% | -7.5% |
| 3M | +212.6% | +5.0% | +207.6% | +224.2% |
| 6M | +309.0% | -29.3% | +338.3% | +297.3% |
| YTD | +567.3% | -13.8% | +581.2% | +585.9% |
| 1Y | +689.7% | -19.6% | +709.3% | +704.1% |
| All | +359.6% | -76.0% | +435.6% | +277.1% |
Cumulative growth
Daily Returns
Daily percentage return beside PLTD.
Daily Out/Under-Performance
Portfolio return minus PLTD return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × PLTD return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded PLTD wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling